Prevacid

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prevacid

Property Description
Active ingredient Lansoprazol (INN)
Form Oral Delayed-Release Capsules/Tablets
Pharmacological class Proton Pump Inhibitor (PPI)
General purpose Suppresses gastric acid secretion
Origin Synthetic substituted benzimidazole

What is Prevacid: Active Ingredient and Drug Classification

Prevacid is the trade name for the active ingredient Lansoprazol, a synthetic compound categorized as a Proton Pump Inhibitor (PPI). This classification places Prevacid within a group of medicines recognized for their powerful antisecretory action, which fundamentally means reducing the stomach's acid production.

Lansoprazol is identified as a single-ingredient product, providing its therapeutic effect through its chemical structure as a substituted benzimidazole derivative. The compound provides sustained acid control. Prevacid is differentiated by its availability in both prescription (Rx) and Over-the-Counter (OTC) strengths, allowing for varied patient groups to address their acid-related concerns.


How Lansoprazol Achieves Acid Suppression

The general purpose of Lansoprazol is to create a less acidic environment in the upper gastrointestinal tract to promote comfort and healing. It achieves this through its antisecretory mechanism, where it targets the Proton Pump (H+,K+-ATPase enzyme) within the gastric parietal cell.

Lansoprazol's mechanism provides a highly reliable suppression of acid secretion that can last for 24 hours. This action makes Lansoprazol typically used in situations where persistent acid blockade is necessary, such as managing frequent episodes of heartburn or acid irritation. By blocking the final step of acid formation, the medicine ensures irritation is minimized at the source.


Available Forms and Single-Ingredient Composition

Lansoprazol is prepared for oral administration in specialized delayed-release formulations, including capsules and the orally disintegrating tablet known as SoluTab. This distinct delayed-release composition is essential because the Lansoprazol active ingredient is vulnerable to stomach acid.

The product composition utilizes enteric-coated granules that serve as a protective base vehicle, shielding the Lansoprazol until it passes to the intestine for absorption. This controlled delivery system is fundamental to Prevacid's efficacy, ensuring the drug reaches its target site unaltered to achieve its purpose.

Regulatory References

  1. Lansoprazole: MedlinePlus Drug Information

What side effects are possible with Prevacid?

Possible Side Effects and Safety Information

Prevacid (lansoprazole) is generally well-tolerated, but like all medications, it is associated with documented side effects and safety considerations based on governmental regulatory analysis.

Common Adverse Reactions

The most frequently reported adverse reactions, typically occurring in 1% or more of patients in clinical trials, include gastrointestinal effects such as diarrhea, abdominal pain, nausea, and constipation, as well as headache.

Serious and Clinically Significant Risks

Regulatory documentation highlights several serious risks, often associated with long-term use (typically over one year or at high doses):

  • Bone Fracture: Increased risk for osteoporosis-related fractures of the hip, wrist, or spine with long-term, multiple daily dose therapy.
  • Low Magnesium (Hypomagnesemia): Rarely reported, but prolonged use may lead to low magnesium levels, which can cause serious events like tetany, arrhythmias, or seizures.
  • Acute Interstitial Nephritis (AIN): A kidney-related inflammatory reaction that may occur at any time during therapy.
  • C. difficile-Associated Diarrhea (CDAD): PPI therapy may be associated with an increased risk of severe, watery diarrhea caused by Clostridium difficile infection.
  • Vitamin B12 Deficiency: Daily long-term use (e.g., longer than three years) may lead to malabsorption and deficiency of cyanocobalamin.

Safety Considerations for Specific Populations

  • Gastric Malignancy: Symptomatic response to Prevacid does not rule out the presence of stomach cancer. Further diagnostic testing may be required.
  • Pediatric Patients: Use is not recommended in children less than one year of age due to potential safety risks.
  • Phenylketonuria (PKU): The Prevacid SoluTab formulation contains phenylalanine and is a specific risk consideration for patients with PKU.

Regulatory Safety Monitoring: Given the potential for serious events, regulatory labels advise considering monitoring key levels (like magnesium) for patients on prolonged treatment or those using certain concomitant medications (e.g., diuretics or digoxin). Consult prescribing information for full details on drug-drug interactions, which include certain antiretrovirals and high-dose methotrexate.

Overdose and Emergency Response

The official regulatory documentation for Lansoprazole (Prevacid) strictly guides the necessary actions to be taken in the event of an overdose. Overdose experience in human subjects is considered limited, and exposures to doses significantly above the therapeutic range have primarily resulted in transient adverse events consistent with the drug’s established safety profile. No specific, severe organ system toxicities are widely documented from acute human overdose.

In any suspected or confirmed case of overexposure, government regulatory documents mandate that individuals must contact a Poison Control Center or seek immediate medical attention and emergency services. The management approach is defined as strictly symptomatic and supportive because there is no specific antidote known for Lansoprazole. Furthermore, due to the drug’s high degree of plasma protein binding, regulatory information confirms that hemodialysis is not expected to be an effective method for removal from the body.

Upon arrival at a medical facility, procedures such as gastric lavage or the administration of activated charcoal may be considered by healthcare professionals for recent ingestions to potentially reduce systemic absorption. Close monitoring of vital signs and continued clinical observation are required to manage any adverse effects that may emerge.

Therapeutic Uses of Prevacid

What Prevacid Treats: Main Uses and Benefits

Quick Facts

  • Gastroesophageal Reflux Disease (GERD): May help manage symptoms like heartburn.
  • Erosive Esophagitis: May facilitate the healing of damage to the esophagus.
  • Ulcers: Used for the short-term management of active duodenal and benign gastric ulcers.
  • H. pylori: Used in combination with other agents to address H. pylori infection.
  • Pathological Hypersecretion: Indicated for long-term management of conditions like Zollinger-Ellison Syndrome.

Prevacid (lansoprazole) is a prescription option used to manage conditions related to excess stomach acid. The medication may help provide relief from heartburn and other symptoms associated with Gastroesophageal Reflux Disease (GERD). It is also indicated for the treatment of erosive esophagitis, which involves acid-related damage to the lining of the esophagus.

Additionally, this drug is used in the short-term treatment of active duodenal ulcers and benign gastric ulcers. It may also reduce the risk of gastric ulcers associated with the ongoing use of certain nonsteroidal anti-inflammatory drugs (NSAIDs) in at-risk patients. When utilized as part of a regimen with other medications, it may help treat and reduce the risk of recurrence of duodenal ulcers caused by H. pylori bacteria.

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Regulatory documents define who is eligible to use Prevacid (lansoprazole) and for whom its use is strictly restricted or prohibited.

Classification Population / Condition
Contraindicated Patients with known severe hypersensitivity to lansoprazole or formulation components.
Contraindicated Patients receiving products containing rilpivirine, atazanavir, or nelfinavir (due to drug-drug interaction risk).
Not Recommended Infants (1 month to less than 1 year of age), as efficacy is not established in this age group.
Restricted Use Patients with severe hepatic impairment (a dose adjustment should be considered).

Age-Related Eligibility: Prevacid is approved for use in adults, adolescents (12–17), and children (1–11) for labeled indications. Its use is not established and not recommended in infants under one year of age. No dosage adjustment is typically required for older adults (geriatric patients) or patients with renal impairment.

Special Status: Use during pregnancy is allowed only if the potential benefit justifies the potential risk. For lactation, a decision must be made to discontinue nursing or discontinue the drug, considering the importance of the drug to the mother, as it is unknown if the medicine is excreted in human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prevacid (Lansoprazole) can interact with several other medicines, primarily by altering the pH level in the stomach or by affecting drug metabolism via liver enzymes.

Key Interaction Categories

Category Mechanism & Impact Examples of Affected Medicines
pH-Dependent Absorption Increased stomach pH reduces absorption of some medicines. Atazanavir, Nelfinavir, Ketoconazole, Iron salts, Digoxin
Drugs Affecting Metabolism Lansoprazole can inhibit certain CYP450 liver enzymes. Warfarin, Theophylline, Tacrolimus
Active Metabolite Formation Interference with the conversion of a medicine to its active form. Clopidogrel

Specific Regulatory Constraints

Do not use Prevacid with Atazanavir due to the risk of substantially reducing Atazanavir's plasma concentrations, which may lead to loss of therapeutic effect and development of resistance. Use with Nelfinavir should also be avoided. The concurrent use of Sucralfate requires taking it at least 30 minutes after Prevacid, as Sucralfate can delay and reduce the absorption of Lansoprazole.

When co-administered with Warfarin, increased monitoring of the International Normalized Ratio (INR) is necessary. Similarly, blood levels of Tacrolimus and Theophylline must be monitored closely, as their concentrations may be increased or decreased respectively, requiring dose adjustments. Temporary withdrawal of Prevacid should be considered during high-dose administration of Methotrexate.

Mechanism of Action

Irreversible Inhibition of Gastric Acid Secretion

Prevacid (lansoprazole) is a prodrug that is selectively concentrated and activated by the acidic environment within the secretory canaliculi of the gastric parietal cells. The activated form, a sulfonamide derivative, functions as an irreversible covalent inhibitor of the gastric hydrogen/potassium adenosine triphosphatase (H^+/K^+-ATPase), commonly known as the Proton Pump . This enzyme is the final common molecular target responsible for exchanging hydrogen ions for potassium ions across the membrane, constituting the final step of acid secretion.

The resulting inhibition physically blocks HCl production regardless of the initial stimulation (histamine, gastrin, or acetylcholine). Due to the irreversible nature of the covalent bond, the Proton Pump is permanently deactivated. Acid secretion remains reduced until the parietal cell synthesizes and inserts new, functional H^+/K^+-ATPase molecules into its secretory membrane. This mechanism leads to a sustained, measurable reduction in the volume and acidity of gastric output, resulting in a prolonged elevation of gastric pH.

Dosage and Administration Information

Administration and Official Usage Guidelines

Lansoprazole (Prevacid) administration follows specific instructions detailing routes, timing, dosing, and duration patterns. The approved administration methods include the oral route (for capsules, orally disintegrating tablets, and suspension) and the intravenous (IV) route for infusion, which is used when oral intake is not appropriate.

Official Dosing and Frequency

Official dosing schedules vary based on the specific condition being managed. Most short-term and maintenance regimens utilize a once-daily frequency. However, combination protocols, such as those for H. pylori eradication, require administration twice or three times daily. Doses exceeding 120 mg daily for pathological hypersecretory conditions must be given in divided doses. The treatment duration is strictly defined, ranging from short courses of four to eight weeks for acute healing, to continuous, long-term use for conditions like Zollinger-Ellison Syndrome.

Procedural Instructions and Constraints

The medicine should be taken before a meal to ensure proper systemic absorption. The delayed-release capsules must be swallowed whole and must not be crushed, chewed, or opened for sprinkling unless the contents are mixed into specific soft foods or non-carbonated juices for immediate consumption, or with apple juice for nasogastric tube administration. If a dose is missed, patients are instructed not to take two doses to compensate. Adjustments are required for certain populations; for instance, a reduced daily dose of 15 mg is used for patients with severe hepatic impairment, and pediatric dosing is weight-based for children between one and eleven years old.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Clinical research on lansoprazole (Prevacid) continues to focus on its role in managing acid-related disorders, including Gastroesophageal Reflux Disease (GERD), healing erosive esophagitis (EE), and treating pathological hypersecretory conditions like Zollinger-Ellison syndrome (ZES).


Efficacy in Esophagitis and GERD

Multiple randomized, controlled trials (RCTs) have been conducted to evaluate the compound's effect on mucosal healing and symptom relief, often using endoscopic evaluation and patient symptom diaries as primary endpoints.

  • Erosive Esophagitis (EE): Studies comparing 30 mg lansoprazole to placebo over an 8-week period showed significantly higher rates of mucosal healing with the active drug. Healing rates with 30 mg were also shown to be comparable to other proton pump inhibitors (PPIs) in direct comparative trials.
  • Nighttime Heartburn: A placebo-controlled study involving subjects with frequent nighttime heartburn reported that both 15 mg and 30 mg doses were associated with a greater mean percentage of nights without heartburn compared to placebo over a 14-day treatment period.

Long-Term Safety and Tolerability

Long-term observational studies and open-label trials have monitored the safety profile for periods extending beyond one year, particularly for maintenance therapy in healed EE.

The overall tolerability profile of lansoprazole is generally consistent across its class. The most frequently reported adverse events include diarrhea, headache, and abdominal pain.

Area of Long-Term Monitoring Status in Observational Data
Bone Fracture Risk Association suggested in some high-dose, long-term studies.
Infection Risk Association with enteric infections, such as Clostridium difficile, has been raised.

It is important to note that many long-term safety findings are derived from large-scale observational studies, which suggest associations but do not establish a definitive causal link.

Frequently Asked Questions (FAQ)

Common questions about Prevacid (FAQ)


Q: Does Prevacid come in a generic version?

A: Yes, the active ingredient in Prevacid, which is lansoprazole, is available as a generic medicine. Generic versions contain the same active ingredient and are approved by regulatory agencies to work in the same way as the brand-name product.


Q: Can Prevacid be used for stomach ulcers?

A: Regulatory documents indicate that approvals for lansoprazole include the treatment of duodenal ulcers and certain types of gastric ulcers. It is also approved for use in combination protocols aimed at healing ulcers caused by H. pylori infection, as stated in official documents.


Q: Is Prevacid used for conditions other than acid reflux?

A: Official product information indicates that in addition to common acid-related conditions like Gastroesophageal Reflux Disease (GERD), lansoprazole is approved for treating certain types of stomach ulcers and pathological hypersecretory conditions, such as Zollinger-Ellison syndrome.


Q: Can Prevacid cause changes in digestion or bowel movements?

A: Official regulatory documents list several adverse reactions affecting the digestive system. These include diarrhea, abdominal pain, nausea, and constipation.


Q: Is it normal to feel a mild headache when first starting Prevacid?

A: According to official regulatory documents, headache is noted as a commonly reported adverse reaction in clinical studies of lansoprazole. The documents do not specify the exact timing or duration, but headache is listed as a commonly reported effect.


Q: Does Prevacid interact with aspirin or other pain relievers?

A: Regulatory documents describe that lansoprazole can interact with other medicines by altering the pH level in the stomach or by affecting drug breakdown in the liver. The prescribing information should be consulted to check for specific interactions with co-administered medicines, which may include certain pain relievers.


Q: Are there any specific foods to avoid while taking Prevacid?

A: Official labeling for the Over-the-Counter (OTC) formulation describes that certain foods and drinks are known to trigger heartburn symptoms. These can be avoided as a measure for symptom management. Common examples include rich, fatty, and spicy foods, as well as chocolate, caffeine, and alcohol.


Q: Can alcohol be consumed while taking Prevacid?

A: The official instructions for the Over-the-Counter (OTC) version specifically state to 'not take this medicine with alcohol.' The full prescribing information describes this caution.


Q: Is Prevacid safe to use during pregnancy?

A: Official regulatory information advises that the medicine should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. The available human studies are not sufficient to definitively establish or exclude drug-associated risks.


Q: Why do some people need to take Prevacid for many months?

A: Long-term use is associated with treating conditions that require sustained acid suppression over a period of time. This includes maintenance therapy for healing conditions like erosive esophagitis or the treatment of certain rare pathological hypersecretory conditions, which are defined in official documents.


Q: Can Prevacid cause changes in mood or sleep?

A: Regulatory documents list a wide range of documented adverse effects. While severe changes are not listed as common, some nervous system effects, such as dizziness, confusion, or anxiety, have been reported.


Q: What should I do if I forget to take a dose of Prevacid?

A: Official guidance describes the procedure if a dose is missed: to take the dose as soon as it is remembered. If it is almost time for the next dose, the missed dose should be skipped, and the regular schedule resumed. The instructions explicitly caution against taking two doses at the same time to compensate.


Q: Are there specific symptoms that mean I should stop taking Prevacid immediately?

A: Regulatory documentation describes that certain serious symptoms require immediate medical attention. These symptoms include signs of a severe allergic reaction (such as difficulty breathing or swelling) or symptoms related to serious kidney issues like Acute Interstitial Nephritis (such as an unexplained rash or fever).


Q: Is the effect of Prevacid permanent or does the acid return after stopping?

A: The medicine works by temporarily blocking the acid pumps. Following the cessation of therapy, some clinical observations cited in regulatory information suggest there is a potential for a temporary increase in acid secretion as the body’s natural regulation mechanism adjusts.


Q: Does taking Prevacid affect kidney function?

A: Regulatory documentation warns of an association with Acute Interstitial Nephritis (AIN). This is a type of inflammatory reaction in the kidneys that may occur at any time during therapy, making it a safety consideration.


Q: Are there any specific instructions for taking Prevacid capsules?

A: Official instructions describe that the capsule should be swallowed whole. If swallowing is difficult, the contents can be emptied onto specific soft foods or non-carbonated juices, but this mixture must be swallowed immediately.


Q: What is the difference between Prevacid 24HR and the prescription version?

A: The key differences are in the approved dose and the duration of treatment. Prevacid 24HR is the Over-the-Counter (OTC) formulation intended for a short, 14-day course for treating frequent heartburn in adults (18+). The prescription version is used for a wider range of acid-related conditions and for varying durations, including long-term use.


Q: Can Prevacid be taken by older adults (seniors)?

A: Official documentation indicates that no overall differences in the effectiveness or safety profile have been found between older adults and younger patients. Consequently, a dosage adjustment is typically not required for geriatric patients.

How should Prevacid be stored and disposed of?

How to Store and Dispose of Prevacid?

Strict storage and disposal requirements for Prevacid (lansoprazole) are defined in official regulatory documents to ensure drug stability.


Storage Requirements

Storage Condition Official Regulatory Guidance
Temperature Store at 20 C to 25 C (68 F to 77 F); excursions permitted between 15 C and 30 C (59 F and 86 F).
Environmental Protection Protect from moisture and keep out of high heat and humidity. Keep the container tightly closed.
Handling & Stability Do not crush or chew. Opened capsule contents mixed with food or liquid must be swallowed immediately and not prepared for later use.

Disposal and Safety

The medication must be kept out of reach of children. For disposal of unused or expired medication, patients should follow local regulations or use authorized drug take-back programs when available. Specific instructions regarding disposal in household trash may also apply.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prevacid found in:

A-Z Index: